23andMe cuts 40% of staff in restructuring

23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also discontinuing its therapeutics business and winding down its clinical trials; it expects these changes to save $35 million annually. “We are taking these difficult but […]

© 2024 TechCrunch. All rights reserved. For personal use only.

https://techcrunch.com/wp-content/uploads/2015/02/cropped-cropped-favicon-gradient.png?w=32